Windlas Biotech Annual Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2022	Mar-2021	Mar-2020	Mar-2019	Mar-2018
Gross Sales	465.93	427.60	328.85	307.27	352.37
Excise Duty	--	--	--	--	0.16
Net Sales	465.93	427.60	328.85	307.27	352.21
Other Operating Income	--	--	--	--	--
Other Income	6.71	8.74	2.49	53.80	4.33
Total Income	472.64	436.34	331.34	361.07	356.54
Total Expenditure	413.51	400.35	294.85	269.53	312.87
PBIDT	59.13	36	36.49	91.54	43.67
Interest	1.42	1.29	2.53	4.84	6.47
PBDT	57.71	34.71	33.96	86.71	37.20
Depreciation	12.15	12.97	9.29	10.59	17.35
Minority Interest Before NP	--	--	--	--	--
Tax	10.13	4.84	8.57	12.01	9.81
Deferred Tax	(2.66)	1.33	(0.12)	0.29	(1.16)
Reported Profit After Tax	38.09	15.57	16.21	63.82	11.20
Minority Interest After NP	--	(0.26)	--	--	--
Net Profit after Minority Interest	38.09	15.83	16.21	63.82	11.20
Extra-ordinary Items	--	(15.48)	--	41.54	--
Adjusted Profit After Extra-ordinary item	38.09	31.31	16.21	22.28	11.20
EPS (Unit Curr.)	18.58	8.70	8.90	38.61	7.06
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	70	--	--	--	--
Equity	10.90	6.41	6.41	6.41	8.53
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	12.69	8.42	11.10	29.79	12.40
PBDTM(%)	12.39	8.12	10.33	28.22	10.56
PATM(%)	8.18	3.64	4.93	20.77	3.18